Public Profile

Mylan Institutional LLC

Mylan Institutional LLC, a prominent player in the pharmaceutical industry, is headquartered in Ireland (IE) and operates extensively across various global markets. Founded in 1961, the company has established itself as a leader in providing high-quality generic and specialty medications, particularly in the institutional healthcare sector. Mylan Institutional focuses on delivering a diverse range of injectable and non-injectable products, catering to hospitals and healthcare providers. Its commitment to quality and affordability sets it apart in a competitive landscape. Over the years, Mylan has achieved significant milestones, including strategic partnerships and a robust product portfolio that addresses critical healthcare needs. With a strong market position, Mylan Institutional is recognised for its innovative solutions and dedication to improving patient outcomes, making it a trusted name in the pharmaceutical field.

DitchCarbon Score

How does Mylan Institutional LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

32

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Mylan Institutional LLC's score of 32 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Mylan Institutional LLC's reported carbon emissions

Mylan Institutional LLC, headquartered in Ireland (IE), currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or climate commitments in detail. However, the company is likely to be engaged in industry-standard practices aimed at reducing environmental impact, as many pharmaceutical companies are increasingly focusing on sustainability and climate action. As the industry evolves, Mylan may adopt initiatives aligned with global climate goals, potentially including commitments to reduce greenhouse gas emissions across Scope 1, 2, and 3 categories. Stakeholders can expect that Mylan will continue to monitor and report on its environmental performance in the future, reflecting a growing trend towards transparency and accountability in corporate climate strategies.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Mylan Institutional LLC's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Mylan Institutional LLC is in IE, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Mylan Institutional LLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Hikma Labs Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Hikma Pharmaceuticals

GB
Pharmaceutical Preparation Manufacturing
Updated 19 minutes ago

MDD US Operations, LLC

US
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Akorn

US
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Eagle Pharmaceuticals, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers